Blood-Filtering machine tested as bridge to liver transplant
NCT ID NCT07329036
Summary
This study is testing a two-part blood-cleansing system for adults hospitalized with sudden, severe liver failure. The goal is to see if this artificial liver support can stabilize patients' organ function and blood clotting, helping them survive long enough for their own liver to recover or to receive a transplant. Researchers will measure how many patients are alive without a transplant 21 days after starting the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute for Clinical and Experimental Medicine (IKEM)
RECRUITINGPrague, 14200, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.